Cite
HARVARD Citation
Essilini, A. et al. (2018). Pretreatment with standard‐dose intravenous methylprednisolone does not improve outcomes in newly diagnosed immune thrombocytopenia (ITP). European journal of haematology. pp. 412-418. [Online].